Baku 6° C
BioNTech, Pfizer studying new COVID variant
Health
- 26 November, 2021
- 13:30
BioNTech and Pfizer said that experts are studying a new variant of coronavirus discovered in South Africa, more information is expected in two weeks, Report informs.
“We expect more laboratory data in two weeks at the latest,” BioNTech spokesman said, according to Agence France-Presse.
The company stressed that the data will help to understand whether the variant of coronavirus B.1.1.529 could “require a vaccine adjustment” by Pfizer/BioNTech in the event that it spreads worldwide.
Author
Latest News
18:03
President Ilham Aliyev approves Agreement on establishment of Joint Commission on cooperation between Azerbaijan and Algeria
Foreign policy17:53
Azerbaijan, Türkiye, Kazakhstan mull promoting Turkic heritage in Slovakia
Foreign policy17:49
Azerbaijan sees 33-fold surge in copper concentrate production
Industry17:42
Value of ICT services in Azerbaijan rises over 8%
ICT17:33
Photo
Graduation ceremony of Underwater Assault Navy Special Force course held
Military17:29
President Ilham Aliyev ratifies Azerbaijan–Moldova agreement on exchange and mutual protection of classified information
Foreign policy17:13
Erdogan: Türkiye was accused of supporting Azerbaijan during 44-day war
Region17:01
Photo
Court hearing on Karen Hovhannisyan's case gets underway in Azerbaijan
Incident16:50